Antiglaucoma Drug Market Growth Driven by Advanced Therapeutic Innovations
The Antiglaucoma Drug Market is experiencing substantial growth, projected to reach a market size of USD 11.57 billion by 2035, with a compound annual growth rate (CAGR) of 3.17%. This upward trajectory is significantly influenced by the rising prevalence of glaucoma, particularly in North America, where an increasing aging population is amplifying the demand for effective therapeutic options....
0 Comments 0 Shares 17 Views 0 Reviews